, where eGFR = estimated glomerular filtration rate (ml/min/1.73m2), SCR = serum creatinine concentration (µmol/L), and age is expressed in years; INR, international normalized ratio; sPESI = simplified Pulmonary Embolism Severity Index (sPESI score incorporates age, history of malignancy, heart failure/chronic lung disease, heart rate ≥110 beats/minute, systolic BP <100 mmHg and oxyhemoglobin saturation <90%). * The included study cohort incorporated all patients who had hemoglobin assessments on more than one day during admission. Excluded cohort were patients who had none or only one hemoglobin assessment during admission. † Neurodegenerative disease includes dementia and Parkinson's disease. ‡ Shock index = heart rate divided by systolic BP (index >0.7 signify hemodynamic compromise). regression was used to compare 6-month mortality. † The study cohort included all patients who had hemoglobin assessments on more than one day during admission. The excluded cohort were patients who had none or only one hemoglobin assessment during admission. ‡ The adjusted survival analysis factored in differences in baseline characteristics (see Supplementary Table   1 ). In addition to sex, it included the following variables with p<0.10: computed-tomography pulmonary angiogram as imaging modality for diagnosis, concomitant deep vein thrombosis, ischemic heart disease, atrial fibrillation/flutter, neurodegenerative disease, simplified Pulmonary Embolism Severity Index (sPESI), day-1 sodium, INR (international normalized ratio), hemoglobin, and estimated glomerular filtration rate, and blood transfusion during admission. 
